ICD-11 Criteria for Disorders due to use of Volatile Inhalants (6C4B)
Disorders
due to use of volatile inhalants are characterised by the pattern and
consequences of volatile inhalant use. Volatile inhalants include a range of
compounds that are in the gaseous or vapour phase at ambient temperatures and
include various organic solvents, glues, gasoline (petrol), nitrites and gases
such as nitrous oxide, trichloroethane, butane, toluene, fluorocarbons, ether
and halothane. They have a range of pharmacological properties but are
predominantly central nervous system depressants, with many also having
vasoactive effects. They tend to be used by younger persons and may be used
when access to alternative psychoactive substances is difficult or impossible.
Volatile Inhalant Intoxication is well recognized. Volatile inhalants have dependence-producing
properties and Volatile Inhalant Dependence and Volatile Inhalant Withdrawal is
recognized although comparatively uncommon worldwide. Volatile Inhalant-Induced
Mental Disorders are described. They may also cause neurocognitive impairment,
including Dementia.
6C4B.0 Episode of
harmful use of volatile inhalants
An
episode of volatile inhalant use or unintentional exposure (e.g., occupational
exposure) that has caused damage to a person’s physical or mental health or has
resulted in behaviour leading to harm to the health of others. Harm to health
of the individual occurs due to one or more of the following: (1) behaviour
related to intoxication; (2) direct or secondary toxic effects on body organs
and systems; or (3) a harmful route of administration. Harm to health of others
includes any form of physical harm, including trauma, or mental disorder that
is directly attributable to behaviour due to volatile inhalant intoxication on
the part of the person to whom the diagnosis of single episode of harmful use
applies. This diagnosis should not be made if the harm is attributed to a known
pattern of volatile inhalant use.
Exclusions:
- Harmful pattern of use of volatile inhalants (6C4B.1)
- Volatile inhalant dependence (6C4B.2)
6C4B.1 Harmful
pattern of use of volatile inhalants
A
pattern of volatile inhalant use of that has caused damage to a person’s
physical or mental health. The pattern of volatile inhalant use is evident over
a period of at least 12 months if substance use is episodic or at least one
month if use is continuous (i.e., daily or almost daily). Harm to health of the
individual occurs due to one or more of the following: (1) behaviour related to
intoxication; (1) direct or secondary toxic effects on body organs and systems;
or (2) a harmful route of administration. Harm to health of others includes any
form of physical harm, including trauma, or mental disorder that is directly
attributable to behaviour related to volatile inhalant intoxication on the part
of the person to whom the diagnosis of Harmful pattern of use of volatile
inhalants applies.
Exclusions:
- Volatile inhalant dependence (6C4B.2)
- Episode of harmful use of volatile inhalants (6C4B.0)
6C4B.10 Harmful
pattern of use of volatile inhalants, episodic
A
pattern of episodic or intermittent volatile inhalant use that has caused
damage to a person’s physical or mental health or has resulted in behaviour
leading to harm to the health of others. The pattern of episodic volatile
inhalant use is evident over a period of at least 12 months. Harm to health of
the individual occurs due to one or more of the following: (1) behaviour
related to intoxication; (2) direct or secondary toxic effects on body organs
and systems; or (3) a harmful route of administration. Harm to health of others
includes any form of physical harm, including trauma, or mental disorder that
is directly attributable to behaviour related to volatile inhalant intoxication
on the part of the person to whom the diagnosis of Harmful pattern of use of
volatile inhalants applies.
Exclusions:
- Episode of harmful use of volatile inhalants (6C4B.0)
- Volatile inhalant dependence (6C4B.2)
6C4B.11 Harmful
pattern of use of volatile inhalants, continuous
A
pattern of continuous (daily or almost daily) volatile inhalant use that has
caused damage to a person’s physical or mental health or has resulted in
behaviour leading to harm to the health of others. The pattern of continuous
volatile inhalant use is evident over a period of at least one month. Harm to
health of the individual occurs due to one or more of the following: (1)
behaviour related to intoxication; (2) direct or secondary toxic effects on
body organs and systems; or (3) a harmful route of administration. Harm to
health of others includes any form of physical harm, including trauma, or
mental disorder that is directly attributable to behaviour related to volatile
inhalant intoxication on the part of the person to whom the diagnosis of
Harmful pattern of use of volatile inhalants applies.
Exclusions:
- Episode of harmful use of volatile inhalants (6C4B.0)
- Volatile inhalant dependence (6C4B.2)
6C4B.1Z Harmful
pattern of use of volatile inhalants, unspecified
6C4B.2 Volatile
inhalant dependence
Volatile
inhalant dependence is a disorder of regulation of volatile inhalant use
arising from repeated or continuous use of volatile inhalants. The
characteristic feature is a strong internal drive to use volatile inhalants,
which is manifested by impaired ability to control use, increasing priority
given to use over other activities and persistence of use despite harm or
negative consequences. These experiences are often accompanied by a subjective
sensation of urge or craving to use volatile inhalants. Physiological features
of dependence may also be present, including tolerance to the effects of
volatile inhalants, withdrawal symptoms following cessation or reduction in use
of volatile inhalants, or repeated use of volatile inhalants or
pharmacologically similar substances to prevent or alleviate withdrawal
symptoms. The features of dependence are usually evident over a period of at
least 12 months but the diagnosis may be made if volatile inhalant use is
continuous (daily or almost daily) for at least 3 months.
Exclusions:
- Episode of harmful use of volatile inhalants (6C4B.0)
- Harmful pattern of use of volatile inhalants (6C4B.1)
6C4B.20 Volatile
inhalant dependence, current use
Current
volatile inhalant dependence with volatile inhalant use within the past month.
Exclusions:
- Episode of harmful use of volatile inhalants (6C4B.0)
- Harmful pattern of use of volatile inhalants (6C4B.1)
6C4B.21 Volatile
inhalant dependence, early full remission
After
a diagnosis of volatile inhalant dependence, and often following a treatment
episode or other intervention (including self-help intervention), the
individual has been abstinent from volatile inhalants during a period lasting
from between 1 and 12 months.
Exclusions:
- Episode of harmful use of volatile inhalants (6C4B.0)
- Harmful pattern of use of volatile inhalants (6C4B.1)
6C4B.22 Volatile
inhalant dependence, sustained partial remission
After
a diagnosis of Volatile inhalant dependence, and often following a treatment
episode or other intervention (including self-help intervention), there is a
significant reduction in volatile inhalant consumption for more than 12 months,
such that even though intermittent or continuing volatile inhalant use has
occurred during this period, the definitional requirements for dependence have
not been met.
Exclusions:
- Episode of harmful use of volatile inhalants (6C4B.0)
- Harmful pattern of use of volatile inhalants (6C4B.1)
6C4B.23 Volatile
inhalant dependence, sustained full remission
After
a diagnosis of Volatile inhalant dependence, and often following a treatment
episode or other intervention (including self-intervention), the person has
been abstinent from volatile inhalants for 12 months or longer.
Exclusions:
- Episode of harmful use of volatile inhalants (6C4B.0)
- Harmful pattern of use of volatile inhalants (6C4B.1)
6C4B.2Z Volatile
inhalant dependence, unspecified
6C4B.3 Volatile
inhalant intoxication
Volatile
inhalant intoxication is a clinically significant transient condition that
develops during or shortly after the consumption of a volatile inhalant that is
characterised by disturbances in consciousness, cognition, perception, affect,
behaviour, or coordination. These disturbances are caused by the known
pharmacological effects of volatile inhalants and their intensity is closely
related to the amount of volatile inhalant consumed. They are time-limited and
abate as the volatile inhalant is cleared from the body. Presenting features
may include euphoria, impaired judgment, aggression, somnolence, stupor or
coma, dizziness, tremor, lack of coordination, slurred speech, unsteady gait,
lethargy and apathy, psychomotor retardation, and visual disturbances. Muscle
weakness and diplopia may occur. Use of volatile inhalants may cause cardiac
arrhythmia, cardiac arrest, and death. Inhalants containing lead (e.g. some
forms of petrol/gasoline) may cause confusion, irritability, coma and seizures.
Coding
Note: Code aslo the causing condition
Exclusions:
- Possession trance disorder (6B63)
6C4B.4 Volatile
inhalant withdrawal
Volatile
inhalant withdrawal is a clinically significant cluster of symptoms, behaviours
and/or physiological features, varying in degree of severity and duration, that
occurs upon cessation or reduction of use of volatile inhalants in individuals
who have developed Volatile inhalant dependence or have used volatile inhalants
for a prolonged period or in large amounts. Presenting features of Volatile
inhalant withdrawal may include insomnia, anxiety, irritability, dysphoric
mood, shakiness, perspiration, nausea, and transient illusions.
Coding
Note: Code aslo the causing condition
6C4B.5 Volatile
inhalant-induced delirium
Volatile
inhalant-induced delirium is characterised by an acute state of disturbed
attention and awareness with specific features of delirium that develops during
or soon after substance intoxication or withdrawal or during the use of
volatile inhalants. The amount and duration of volatile inhalant use must be
capable of producing delirium. The symptoms are not better explained by a
primary mental disorder, by use of or withdrawal from a different substance, or
by another health condition that is not classified under Mental, behavioural
and neurodevelopmental disorders.
Coding
Note: This category should never be used in primary
tabulation. The codes are provided for use as supplementary or additional codes
when it is desired to identify the presence of dementia in diseases classified
elsewhere.
When
dementia is due to multiple aetiologies, code all that apply.
6C4B.6 Volatile
inhalant-induced psychotic disorder
Volatile
inhalant-induced psychotic disorder is characterised by psychotic symptoms
(e.g. delusions, hallucinations, disorganized thinking, grossly disorganized
behaviour) that develop during or soon after intoxication with or withdrawal
from volatile inhalants. The intensity or duration of the symptoms is
substantially in excess of psychotic-like disturbances of perception,
cognition, or behaviour that are characteristic of Volatile inhalant
intoxication or Volatile inhalant withdrawal. The amount and duration of
volatile inhalant use must be capable of producing psychotic symptoms. The
symptoms are not better explained by a primary mental disorder (e.g.
Schizophrenia, a Mood disorder with psychotic symptoms), as might be the case
if the psychotic symptoms preceded the onset of the volatile inhalant use, if
the symptoms persist for a substantial period of time after cessation of the
volatile inhalant use or withdrawal, or if there is other evidence of a
pre-existing primary mental disorder with psychotic symptoms (e.g. a history of
prior episodes not associated with volatile inhalant use).
Coding
Note: Code
aslo the causing condition
6C4B.7 Certain
specified volatile inhalants-induced mental or behavioural disorders
Coding
Note: Code aslo the causing condition
6C4B.70 Volatile
inhalant-induced mood disorder
Volatile
inhalant-induced mood disorder is characterised by mood symptoms (e.g.,
depressed or elevated mood, decreased engagement in pleasurable activities, increased
or decreased energy levels) that develop during or soon after intoxication with
or withdrawal from volatile inhalants. The intensity or duration of the
symptoms is substantially in excess of mood disturbances that are
characteristic of Volatile inhalant intoxication or Volatile inhalant
withdrawal. The amount and duration of volatile inhalant use must be capable of
producing mood symptoms. The symptoms are not better explained by a primary
mental disorder (e.g., a Depressive disorder, a Bipolar disorder,
Schizoaffective disorder), as might be the case if the mood symptoms preceded
the onset of the volatile inhalant use, if the symptoms persist for a
substantial period of time after cessation of the volatile inhalant use or
withdrawal, or if there is other evidence of a pre-existing primary mental
disorder with mood symptoms (e.g., a history of prior episodes not associated
with volatile inhalant use).
Coding
Note:
Code aslo the causing condition
6C4B.71 Volatile
inhalant-induced anxiety disorder
Volatile
inhalant-induced anxiety disorder is characterised by anxiety symptoms (e.g.,
apprehension or worry, fear, physiological symptoms of excessive autonomic
arousal, avoidance behaviour) that develop during or soon after intoxication with
or withdrawal from volatile inhalants. The intensity or duration of the
symptoms is substantially in excess of anxiety symptoms that are characteristic
of Volatile inhalant intoxication or Volatile inhalant withdrawal. The amount
and duration of volatile inhalant use must be capable of producing anxiety
symptoms. The symptoms are not better explained by a primary mental disorder
(e.g., an Anxiety and Fear-Related Disorder, a Depressive Disorder with
prominent anxiety symptoms), as might be the case if the anxiety symptoms
preceded the onset of the volatile inhalant use, if the symptoms persist for a
substantial period of time after cessation of the volatile inhalant use or
withdrawal, or if there is other evidence of a pre-existing primary mental
disorder with anxiety symptoms (e.g., a history of prior episodes not
associated with volatile inhalant use).
Coding
Note: Code aslo the causing condition
6C4B.Y Other
specified disorders due to use of volatile inhalants
6C4B.Z Disorders
due to use of volatile inhalants, unspecified
REFERENCE:
International Classification of Diseases Eleventh Revision (ICD-11). Geneva: World Health Organization; 2022. License: CC BY-ND 3.0 IGO.
https://creativecommons.org/licenses/by-nc-nd/3.0/igo/
Comments
Post a Comment
Your Thoughts?